Maha FDA Writes To Central Govt Asking It To Cap Remdesivir Rate

Mumbai, 7 March 2021:

With cases surging in the state, the Maharashtra Food and Drugs Administration (FDA) is working to bring down cost of the remdesivir injection, used for treating critical Covid-19 cases.

The FDA has sent a proposal to the Central government to fix the maximum retail price of 100 mg of the injection under the drugs price control, 2013. The state had in December 2020 capped the price of the injection at Rs 2,360. However, since the injection is sold by six major manufacturers to hospitals and wholesalers for Rs 800 to Rs. 1200, it should be available at a much cheaper rate than the current MRP that ranges from Rs 2,800 to Rs 5,400, the state feels. The Times Of India